Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis

Objective Glial fibrillary acidic protein (GFAP) is expressed in astrocytes and may be a useful marker of non‐active progressive multiple sclerosis (MS). We evaluate serum GFAP (sGFAP) in a large cohort of MS patients to determine if it predicts progression independent of relapse activity (PIRA), fu...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Annals of clinical and translational neurology Ročník 11; číslo 10; s. 2719 - 2730
Hlavní autori:	Madill, Evan, Healy, Brian C., Molazadeh, Negar, Polgar‐Turcsanyi, Mariann, Glanz, Bonnie I., Weiner, Howard L., Chitnis, Tanuja
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States John Wiley & Sons, Inc 01.10.2024 John Wiley and Sons Inc Wiley
Predmet:	Adult Age Biomarkers Biomarkers - blood Cerebrospinal fluid Cognitive Dysfunction - blood Cognitive Dysfunction - etiology Cognitive Dysfunction - physiopathology Disease Progression Female Gait Glial Fibrillary Acidic Protein - blood Humans Male Middle Aged Multiple sclerosis Multiple Sclerosis - blood Multiple Sclerosis - physiopathology Multiple Sclerosis, Chronic Progressive - blood Multiple Sclerosis, Chronic Progressive - physiopathology Patients Proteins Regression analysis United States > US
ISSN:	2328-9503, 2328-9503
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!